Showing results 1 to 20 of 28  next >
Publication YearJRC N°TitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2007JRC38225213bi-Induced Death of Hsc45-M2 Gastric Cancer Cells Is Characterized by G2 Arrest and Up-Regulation of Genes Known to Prevent Apoptosis but Induce Necrosis and Mitotic CatastrpopheSEIDL C.; PORT M.; GILBERTZ K.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SCHWAIGER M.; ROEPER B.; SENEKOWITSCH-SCHMIDTKE R.; ABEND M.Articles in periodicals and books
2007JRC41950213Bi-radioimmunotherapy Defeats Early-stage Disseminated Gastric Cancer in Nude MiceBECK R.; SEIDL C.; PFOST B.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; BAUM M.; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Articles in periodicals and books
2017JRC106139225Ac-DOTA-Substance P as a potential radiopharmaceutical for targeted alpha therapy of glioblastoma multiformeMAJKOWSKA PILIP AGNIESZKA; RIUS MONTRAVETA MARIA; BRUCHERTSEIFER FRANK; APOSTOLIDIS CHRISTOS; WEIS MIRJAM; BONELLI MILTON; LAURENZA MARTA; MORGENSTERN ALFREDArticles in periodicals and books
2017JRC106148225Ac-PSMA617: PSMA targeting alpha-radiation therapy of patients with mCRPCKRATOCHWIL CLEMENS; BRUCHERTSEIFER FRANK; GIESEL FREDERIK; APOSTOLIDIS CHRISTOS; HABERKORN UWE; MORGENSTERN ALFREDArticles in periodicals and books
2017JRC106137Assessing 225Ac-Polymersomes for Targeted Radionuclide TherapyDE KRUIJFF R. M.; HESKAMP SANDRA; VAN DER MEER A; KOUWENBERG J; TORRELO VILLA G; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SMINIA P; DENKOVA A.G.Articles in periodicals and books
2017JRC105961Assessment of 213Bi-anti-EGFR-MAb treatment response in malignant cancer cellsFEUERECKER BENEDIKT; RANDL PHILIPP; SEIDL C.; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SCHWAIGER M.; EISENREICH WOLFGANGArticles in periodicals and books
2017JRC105960Barium ferrite nanoparticles labeled with 223Ra: a new potential radiobioconjugate for internal alpha therapyMALISZEWSKA W; CĘDROWSKA E; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; BILEWICZ ALEKSANDERArticles in periodicals and books
2017JRC106154Bi-213-anti-EGFR-MAb therapy of recurrent bladder cancer – a pilot studySCHEIDHAUER KLEMENS; SEIDL C.; BRUCHERTSEIFER FRANK; APOSTOLIDIS CHRISTOS; AUTENRIETH MICHAEL; KURTZ F; HORN THOMAS; SCHWAIGER MARKUS; GSCHWEND J.E.; D'ALESSANDRIA C, et alArticles in periodicals and books
2017JRC106150Biodistribution, dosimetry and imaging of 225Ac-DOTA-anti-PD-L1-BC in a murine immunocompetent transgenic breast cancer modelJOSEFSSON ANDERS; NEDROW JESSIE; PARK SUNJU; BAECK TOM; HOBBS ROBERT F.; BRAYTON CORY; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SGOUROS G.Articles in periodicals and books
2017JRC106151Correspondence between alpha-particle emitter dosimetry and normal organ toxicityJOSEFSSON ANDERS; NEDROW JESSIE; HOBBS ROBERT F.; BAECK TOM; PARK SUNJU; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SGOUROS GEORGEArticles in periodicals and books
2008JRC44967Development and Evaluation of Peptidic Ligands Targeting Tumor-associated Urokinase Plasminogen Activator Receptor (uPAR) for Use in Alpha-emitter Therapy of Disseminated Ovarian CancerKNOER S.; SATO S.; HUBER T.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SCHMITT M.; KESSLER H.; SENEKOWITSCH-SCHMIDTKE R.; MAGDOLEN V.; SEIDL C.Articles in periodicals and books
2007JRC41945Gemcitabine Radiosensitizes Multiple Myeloma Cells to Low LET, but not High LET, IrradiationSUPIOT S.; THILLAYS F.; RIO E.; GOUARD S.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; MAHE M. A.; CHATAL J. F.; DAVODEAU F.; CHEREL M.Articles in periodicals and books
2017JRC106152The impact of tumor burden on the absorbed dose to the kidneys from Actinium-225 labeled antibody therapy in a murine model and predicted dosimetric impact for human clinical useJOSEFSSON ANDERS; NEDROW JESSIE; PARK SUNJU; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SGOUROS G.; HOBBS ROBERT F.Articles in periodicals and books
2017JRC103932Improved 225Ac daughter retention in InPO4 containing polymersomesDE KRUIJFF R. M.; DROST K; THIJSSEN L; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; LATHOUWERS D.; WOLTERBEEK H.TH.; DENKOVA A.G.Articles in periodicals and books
2007JRC37786An Improved Method for the Production of Ac-225/Bi-213 from Th-229 for Targeted Alpha TherapyZIELINSKA Barbara; APOSTOLIDIS CHRISTOS; BRUCHERTSEIFER FRANK; MORGENSTERN ALFREDArticles in periodicals and books
2017JRC105936In Vitro comparison of 213Bi- and 177Lu-radiation for peptide receptor radionuclide therapyCHAN HO SZE; DE BLOIS ERIK; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; DE JONG MARION; BREEMAN W.A.P.; KONIJNENBERG M.W.Articles in periodicals and books
2017JRC106140Involvement of direct and indirect (bystander) cytotoxic effects in alpha-RIT of small volume peritoneal carcinomatosis using 213Bi- and ²¹²Pb-labeled mAbsLADJOHOUNLOU RIAD; PICHARD ALEXANDRE; BOUDOUSQ VINCENT; PAILLAS SALOME; LOZZA CATHERINE; MARCATILI SARA; BARDIÈS M; CHOUIN N; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED, et alArticles in periodicals and books
2017JRC106147Novel IgG to melanin shows promise for radioimmunotherapy of metastatic melanomaDADACHOVA EKATERINA; REVSKAYA EKATERINA; JEYAKUMAR A; JIANG Z.; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; RICKLES DArticles in periodicals and books
2017JRC105539An octadentate chelator based on 3,4-hydroxypyridinones for 89Zr4+ and 213Bi3+ chelationCUSNIR RUSLAN; FOLEY CALUM A; LANGE JACLYN L; IMBERTI CINZIA; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; BLOWER PHIL; MA MICHELLEArticles in periodicals and books
2017JRC106141Pharmacokinetic profiling and therapeutic efficacy of alpha-emitter labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer modelNEDROW JESSIE; JOSEFSSON ANDERS; PARK SUNJU; BAECK TOM; HOBBS ROBERT F.; BRAYTON CORY; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SGOUROS G.Articles in periodicals and books